التفاصيل البيبلوغرافية
| العنوان: |
Securing the supply of benzathine penicillin: a global perspective on risks and mitigation strategies to prevent future shortages. |
| المؤلفون: |
Seghers, Frederic, Taylor, Melanie M, Storey, Andrew, Dong, Jicui, Wi, Teodora C, Wyber, Rosemary, Ralston, Kate, Nguimfack, Boniface Dongmo |
| المصدر: |
International Health (1876-3413); May2024, Vol. 16 Issue 3, p279-282, 4p |
| مصطلحات موضوعية: |
RHEUMATIC heart disease, RHEUMATIC fever, PENICILLIN, STREPTOCOCCAL diseases, SCARCITY |
| مستخلص: |
Benzathine benzylpenicillin is a globally indispensable medicine. As a long-lasting injectable penicillin, it serves as the primary treatment for syphilis, group A streptococcal infections, rheumatic fever and rheumatic heart disease. A competitive market and low profit margins, compounded by limited visibility of demand, have resulted in a decreased number of active pharmaceutical ingredient (API) manufacturers. By 2016, only three Chinese API manufacturers remained, continuing to supply to the global market today. Recurring global shortages, a consequence of supply and demand imbalances, indicate underlying market risks. Therefore, the need for mitigation strategies is imperative. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Health (1876-3413) is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
